Back to ExodusPoint Capital Management, LP ExodusPoint Capital Management, LP

RNARNA
2 quarters

Position history for ExodusPoint Capital Management, LPExodusPoint Capital Management, LP's holdings in ATRIUM THERAPEUTICS INC

ExodusPoint Capital Management, LP holds 117,275 shares of RNA (ATRIUM THERAPEUTICS INC), worth $1.6M as of 2026-Q2. The position was increased (+51.4% shares). RNA represents 0.0% of ExodusPoint Capital Management, LP's portfolio.

Current Value

$1.6M

Current Shares

117,275

Total Value Change

+$541,949

Total Shares Change

+39,833

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
117,275
+51.4%
$1.6M0.0%$13.45
36
2026-Q1
New
77,442
-
$1M0.0%$15.67
35

Other major holders of RNA: PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used